We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$10.2B
AUM Growth
+$231M
Cap. Flow
-$62.1M
Cap. Flow %
-0.61%
Top 10 Hldgs %
71.27%
Holding
101
New
7
Increased
18
Reduced
30
Closed
9

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.06%
2 Financials 17.97%
3 Healthcare 15.31%
4 Technology 13.48%
5 Communication Services 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
26
Weyerhaeuser
WY
$17.5B
$36M 0.35%
1,009,876
-100,880
-9% -$3.43M
DXCM icon
27
DexCom
DXCM
$29.1B
$34.9M 0.34%
388,000
EXAS
28
DELISTED
Exact Sciences
EXAS
$33.9M 0.33%
256,864
-30,000
-10% -$4.11M
ISRG icon
29
Intuitive Surgical
ISRG
$128B
$31M 0.3%
125,811
EW icon
30
Edwards Lifesciences
EW
$49.2B
$28.5M 0.28%
341,311
CNC icon
31
Centene
CNC
$31.2B
$26.5M 0.26%
414,756
EDU icon
32
New Oriental
EDU
$9.12B
$26.3M 0.26%
187,788
+2,206
+1% +$385K
TAL icon
33
TAL Education Group
TAL
$6.06B
$25.8M 0.25%
478,444
+13,190
+3% +$966K
TFX icon
34
Teleflex
TFX
$5.85B
$24.1M 0.24%
58,000
AXNX
35
DELISTED
Axonics, Inc. Common Stock
AXNX
$24M 0.23%
400,000
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$124B
$23.3M 0.23%
108,557
+20,000
+23% +$4.39M
ILMN icon
37
Illumina
ILMN
$29.2B
$22.3M 0.22%
59,601
LHCG
38
DELISTED
LHC Group LLC
LHCG
$21.2M 0.21%
110,657
AERI
39
DELISTED
Aerie Pharmaceuticals
AERI
$20.7M 0.2%
1,156,142
-300,000
-21% -$5.18M
QDEL icon
40
QuidelOrtho
QDEL
$1.13B
$20.5M 0.2%
160,000
+25,000
+19% +$4.62M
HRTX icon
41
Heron Therapeutics
HRTX
$93.7M
$19.5M 0.19%
1,202,069
PODD icon
42
Insulet
PODD
$11.7B
$19M 0.19%
72,908
TDOC icon
43
Teladoc Health
TDOC
$1.69B
$17.3M 0.17%
95,000
+55,000
+138% +$12.8M
BHVN
44
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$16.9M 0.17%
247,498
+60,000
+32% +$4.85M
NVCR icon
45
NovoCure
NVCR
$1.81B
$16.8M 0.16%
126,784
-35,000
-22% -$5.54M
GKOS icon
46
Glaukos
GKOS
$9.19B
$16.6M 0.16%
197,212
-50,000
-20% -$4.4M
CHRS icon
47
Coherus Oncology
CHRS
$222M
$15.5M 0.15%
1,058,464
ALGN icon
48
Align Technology
ALGN
$12.9B
$15.4M 0.15%
28,428
TVRD
49
Tvardi Therapeutics
TVRD
$22.5M
$15.3M 0.15%
19,541
KRYS icon
50
Krystal Biotech
KRYS
$10.6B
$14.3M 0.14%
185,809

Similar funds

C WorldWide Group's Q1 2021 Portfolio in Review

As of Q1 2021, C WorldWide Group held 101 positions worth $10.2B, up 2.3% from $9.98B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

C WorldWide Group's Q1 2021 filing shows 7 new, 18 increased, 30 reduced and 9 closed positions. Its largest new stake was Trip.com Group: 1,149,327 shares worth $45.5M. The largest sale was Coca-Cola, an estimated $371M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • C WorldWide Group's largest Q1 2021 buy was Trip.com Group: 1,149,327 shares worth $45.5M.
  • C WorldWide Group added most to Fiserv Inc in Q1 2021, an estimated $374M increase.
  • C WorldWide Group's biggest Q1 2021 reduction was Coca-Cola, cutting an estimated $371M.
  • C WorldWide Group fully exited Merck in Q1 2021, selling an estimated $15.3M.
  • C WorldWide Group's ten largest holdings make up 71% of its $10.2B portfolio in Q1 2021.
  • C WorldWide Group opened 7 new positions and closed 9 in Q1 2021.
  • C WorldWide Group's portfolio value rose 2.3% quarter-over-quarter to $10.2B.

Based on C WorldWide Group's 13F filing for Q1 2021, filed 4 May 2021.